Follicular lymphoma grade IIIb, extranodal and solid organ sites
ICD-10 C82.49 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiib, extranodal and solid organ sites.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIb indicates a more aggressive form of the disease, where there is a predominance of large cells, often leading to a poorer prognosis compared to lower grades. Extranodal involvement refers to the lymphoma's spread beyond lymph nodes to other organs, such as the liver, spleen, or bone marrow. Patients may present with B-symptoms, which include fever, night sweats, and weight loss, indicating systemic involvement. Diagnosis typically involves imaging studies, biopsy, and immunophenotyping to confirm the presence of malignant B-cells. Treatment protocols may include chemotherapy, immunotherapy, or targeted therapies, depending on the stage and extent of the disease. The management of follicular lymphoma is complex and requires a multidisciplinary approach, often involving oncologists, radiologists, and pathologists.
Comprehensive documentation of diagnosis, staging, treatment plans, and response to therapy.
Initial diagnosis of lymphoma, treatment planning, and follow-up assessments.
Ensure accurate grading and staging are documented to support coding.
Detailed pathology reports including histological grading and immunophenotyping results.
Biopsy interpretation and reporting of lymphoma types.
Clear communication of findings to support accurate coding by other specialties.
Used for outpatient chemotherapy administration for patients with follicular lymphoma.
Document the specific chemotherapy regimen and patient response.
Oncology specialists should ensure accurate coding of chemotherapy administration.
Key symptoms include B-symptoms such as fever, night sweats, and weight loss, along with lymphadenopathy and possible extranodal involvement.
